Health In Tech, Inc.

NASDAQ:HIT

Software - Application

Technology
$0.93 +0.00%

+$0.00 today

Market cap
$50.13M
Beta
2.94
P/E (TTM)
-75.2
EPS (TTM)
-$0.01
52W Low $0.59High $4.02

Volume 0.04M

Average 0.23M

HIT Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Health In Tech, Inc.NASDAQ: HIT

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development growth accelerates

Q1 FY2026 research & development of $920.4K rose 71.2% year over year, ahead of the -24.7% change in trailing-twelve-month research & development. Sequentially, it rose 331.9% from the prior quarter. Over 3 fiscal years it compounded at +25.5% a year.

Context

  • Research & development amounted to 4.7% of revenue in FY2025, down 9.7 pp from a year earlier.
  • Research & development increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +71.2% holds above the trailing-twelve-month pace of -24.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$920.4K+331.9% QoQ
Last fiscal yearDec 2025
$1.57M-44.2% YoY
LTMMar 2026
$1.95M-24.7% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+71.2%——
1 year-44.2%——
3-year CAGR+25.5%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
1.57M USD
Year-over-year change
-44.2%
3-year CAGR
+25.5%

Research & Development vs competitors

How HIT compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -24.7% is the 6th highest of 7, against a peer median of -5.2%.
  • Research & development amounts to 5.7% of revenue for HIT, versus a peer median of 12.8%.
HIT Competitors
Research & Development for HIT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LAWRRobot Consulting Co., Ltd. ADSFY2025¥86.16M JPY-16.7%+6.5%12.8%
TEADTeads Holding Co.LTM Mar 2026$40.26M USD-3.8%+2.6%3.1%
SVCOSilvaco Group, Inc. Common StockLTM Mar 2026$33.82M USD+54.3%+33.9%50.7%
STEMStem, Inc.LTM Mar 2026$30.54M USD-37.0%-2.7%20.0%
DSPViant Technology Inc.LTM Mar 2026$30.29M USD+19.2%+12.8%8.4%
EXFYExpensify, Inc.LTM Mar 2026$22.49M USD-6.6%+14.7%16.1%
HITHealth In Tech, Inc.LTM Mar 2026$1.95M USD-24.7%+25.5%5.7%
TROOTROOPS, Inc.FY2025$0 USD——0.0%
Peer median (excluding HIT) —-5.2%+9.6%12.8%

Competitors are the stored peer set for HIT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue5.77M19.15M19.49M33.33M
Cost of Revenue334.19K2.3M4.05M12.39M
Gross Profit5.44M16.85M15.44M20.94M
Gross Margin94.2%88.0%79.2%62.8%
Research & Development794.62K2M2.81M1.57M
Selling, General & Admin4.44M11.46M11.64M17.84M
Operating Expenses5.23M13.46M14.45M19.41M
Depreciation & Amortization0339.3K541.14K900.58K
EBITDA205.58K3.76M1.93M2.57M
EBITDA Margin3.6%19.6%9.9%7.7%
Operating Income205.58K3.38M989.9K1.53M
Operating Margin3.6%17.7%5.1%4.6%
Interest Income040.86K122.89K409.92K
Interest Expense4.57K2.05K495K0
Other Income / Expenses(4.57K)38.81K(100.9K)145.73K
Income Before Tax201.01K3.42M889K1.67M
Pre-Tax Margin3.5%17.9%4.6%5.0%
Income Tax Expense121.27K945.24K218.52K395.33K
Net Income79.74K2.48M670.48K1.28M
Net Margin1.4%12.9%3.4%3.8%
EPS (Basic)0.000.050.010.02
EPS (Diluted)0.000.050.010.02
Weighted Avg Shares54.07M54.07M67.05M55.84M
Weighted Avg Shares (Diluted)54.07M54.07M53.66M57.74M

Health In Tech, Inc.

NASDAQ:HIT

Intrinsic Alpha fair value

Locked

Current Price

$0.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.